Galapagos NV Profile Avatar - Palmy Investing

Galapagos NV

Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of …
Biotechnology
BE, Mechelen [HQ]
GLPGF/Leadership and Strategy

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of GLPGF's Analysis
CIK: 1421876 CUSIP: - LEI: - UEI: -
Secondary Listings